{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T05:45:52Z","timestamp":1750657552478},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"The Sanming Project of Medicine in Shenzhen","award":["SZSM201612080"],"award-info":[{"award-number":["SZSM201612080"]}]},{"name":"Shenzhen Science and Technology Plan Project","award":["JCYJ20180302173532311"],"award-info":[{"award-number":["JCYJ20180302173532311"]}]},{"name":"Shenzhen Municipal Health and Family Planning Research Project","award":["SZXJ2018005"],"award-info":[{"award-number":["SZXJ2018005"]}]},{"name":"Shenzhen Science and Technology Plan Project","award":["JCYJ20170817094922513"],"award-info":[{"award-number":["JCYJ20170817094922513"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Our objective was to determine whether initiation of febuxostat during an acute gout flare prolongs the current episode.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this randomized, placebo-controlled, single-blinded, multicentre trial, patients with acute gout flares within 72\u2009h were randomized (1:1) to the placebo and febuxostat (40\u2009mg\/day) groups. All patients were administered diclofenac (150\u2009mg\/day) for 7\u2009days and then open-labelled on the eighth day. Febuxostat 40\u2009mg daily and diclofenac 75\u2009mg daily were administered from day 8 through 28 for the remission period. The dose of diclofenac was 150\u2009mg\/day before remission in both arms, and the original protocol was maintained until remission. The primary outcome was \u2018days to resolution\u2019.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We randomized 140 patients, 70 into each arm. The mean days to resolution was 5.98\u2009days [median 7.00, interquartile range (IQR) 2.45\u2009days] for the placebo and 6.50\u2009days (median 7.00, IQR 3.67\u2009days) for the febuxostat group (P\u00a0=\u00a00.578). The rate of resolution within 7\u2009days was 84.38% for the placebo group and 76.92% for the febuxostat group (P\u00a0=\u00a00.284). There were no statistically significant differences in joint pain, swelling, tenderness and erythema scores at days 1, 3, 5 and 7. The mean serum uric acid levels were 507.54 and 362.62 \u03bcmol\/l for the placebo and febuxostat group, respectively, on day 7 (P\u00a0=\u00a00.000). The rate of recurrent gout flares was 10.00% for the placebo group and 6.56% for the febuxostat group from day 8 through 28 (P\u00a0=\u00a00.492).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Initiation of febuxostat administration during an acute gout flare did not prolong the duration of acute flares.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration<\/jats:title>\n                  <jats:p>Chinese Clinical Trial Registry, http:\/\/www.chictr.org.cn\/, ChiCTR1800015962<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa908","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T17:36:16Z","timestamp":1608226576000},"page":"4199-4204","source":"Crossref","is-referenced-by-count":7,"title":["Initiation of febuxostat for acute gout flare does not prolong the current episode: a randomized clinical trial"],"prefix":"10.1093","volume":"60","author":[{"given":"Ertao","family":"Jia","sequence":"first","affiliation":[{"name":"The Department of Rheumatology, the Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanying","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Department of Rheumatology, the Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wukai","family":"Ma","sequence":"additional","affiliation":[{"name":"The Department of Rheumatology, the Second Affiliated Hospital of Guizhou University of traditional Chinese Medicine, Guiyang"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[{"name":"The Department of Rheumatology, People's Hospital of Longhua District Shenzhen, Shenzhen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongling","family":"Geng","sequence":"additional","affiliation":[{"name":"The Department of Gynecology, Guangdong Provincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhong","sequence":"additional","affiliation":[{"name":"The Department of Rheumatology, the Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueming","family":"Yao","sequence":"additional","affiliation":[{"name":"The Department of Rheumatology, the Second Affiliated Hospital of Guizhou University of traditional Chinese Medicine, Guiyang"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Xie","sequence":"additional","affiliation":[{"name":"The Department of Rheumatology, the Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Xiao","sequence":"additional","affiliation":[{"name":"The Department of Rheumatology, the Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yubao","family":"Jiang","sequence":"additional","affiliation":[{"name":"The Department of Rheumatology, the Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Qiu","sequence":"additional","affiliation":[{"name":"The Department of Rheumatology, the Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Xiao","sequence":"additional","affiliation":[{"name":"The Department of Rheumatology, the Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Cui","sequence":"additional","affiliation":[{"name":"The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Wei","sequence":"additional","affiliation":[{"name":"The Department of Rheumatology, the Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyong","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Department of Rheumatology, the Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"2021090119435883700_keaa908-B1","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2021090119435883700_keaa908-B2","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res"},{"key":"2021090119435883700_keaa908-B3","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/art.41247","article-title":"2020 American College of Rheumatology Guideline for the management of gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2021090119435883700_keaa908-B4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.rdc.2005.10.003","article-title":"Newer therapeutic approaches: gout","volume":"32","author":"Schumacher","year":"2006","journal-title":"Rheum Dis Clin N Am"},{"key":"2021090119435883700_keaa908-B5","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout","volume":"353","author":"Becker","year":"2005","journal-title":"N Engl J Med"},{"key":"2021090119435883700_keaa908-B6","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/rheumatology\/kem178","article-title":"Assessment of outcome in clinical trials of gout - A review of current measures","volume":"46","author":"Taylor","year":"2007","journal-title":"Rheumatology"},{"key":"2021090119435883700_keaa908-B7","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3899\/jrheum.081296","article-title":"Impact of a rheumatology consultation service on the diagnostic accuracy and management of gout in hospitalized patients","volume":"36","author":"Barber","year":"2009","journal-title":"J Rheumatol"},{"key":"2021090119435883700_keaa908-B8","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/art.22767","article-title":"Quality of care for gout in the US needs improvement","volume":"57","author":"Singh","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2021090119435883700_keaa908-B9","first-page":"29","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","author":"Richette","year":"2017"},{"key":"2021090119435883700_keaa908-B10","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/RHU.0000000000000235","article-title":"Does starting allopurinol prolong acute treated gout? A randomized clinical trial","volume":"21","author":"Hill","year":"2015","journal-title":"J Clin Rheumatol"},{"key":"2021090119435883700_keaa908-B11","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.amjmed.2012.05.025","article-title":"Initiation of allopurinol at first medical contact for acute attacks of gout: a randomized clinical trial","volume":"125","author":"Taylor","year":"2012","journal-title":"Am J Med"},{"key":"2021090119435883700_keaa908-B12","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jbspin.2015.02.021","article-title":"Significance of the initiation time of urate-lowering therapy in gout patients: a retrospective research","volume":"82","author":"Feng","year":"2015","journal-title":"Jt Bone Spine"},{"key":"2021090119435883700_keaa908-B13","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3899\/jrheum.080814","article-title":"Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout","volume":"36","author":"Becker","year":"2009","journal-title":"J Rheumatol"},{"key":"2021090119435883700_keaa908-B14","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.1780200320","article-title":"Preliminary criteria for the classification of the acute arthritis of primary gout","volume":"20","author":"Wallace","year":"1977","journal-title":"Arthritis Rheum"},{"key":"2021090119435883700_keaa908-B15","doi-asserted-by":"crossref","first-page":"e036748","DOI":"10.1136\/bmjopen-2019-036748","article-title":"Comparative efficacy of traditional non-selective NSAIDs and selective cyclo-oxygenase-2 inhibitors in patients with acute gout: a systematic review and meta-analysis","volume":"10","author":"Li","year":"2020","journal-title":"BMJ Open"},{"key":"2021090119435883700_keaa908-B16","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","article-title":"2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"74","author":"Neogi","year":"2015","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaa908\/35466672\/keaa908.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/9\/4199\/40215087\/keaa908.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/9\/4199\/40215087\/keaa908.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T19:45:16Z","timestamp":1630525516000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/9\/4199\/6065952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":16,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,1,6]]},"published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa908","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9,1]]},"published":{"date-parts":[[2021,1,6]]}}}